Intrabdominal Hyperthermic Chemotherapy and Pancreatic Cancer
NCT03251365
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Resectable Pancreatic Adenocarcinoma
Interventions
DRUG:
HIPEC-gemcitabine
Sponsor
Hospital General de Ciudad Real